Text Size

Loving-kindness Meditation for Posttraumatic Stress Disorder (PTSD)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
David Kearney, Seattle Institute for Biomedical and Clinical Research
ClinicalTrials.gov Identifier:
NCT01607632
First received: May 23, 2012
Last updated: May 24, 2012
Last verified: May 2012
History of Changes
  Purpose

A before and after study of veterans who took part in a 12-week loving-kindness meditation course as an adjunct to their usual care for posttraumatic stress disorder.


Condition Intervention
Posttraumatic Stress Disorder
 Behavioral: loving-kindness meditation

Study Type: Interventional
Study Design: Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: An Open Pilot Study of Loving-Kindness Meditation for PTSD

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by Seattle Institute for Biomedical and Clinical Research:

Primary Outcome Measures:
  • change in PTSD symptoms [ Time Frame: baseline, post-intervention, 3-month follow-up ] [ Designated as safety issue: Yes ]
    The PTSD symptom-scale interview was performed

  • change in depressive symptoms [ Time Frame: baseline, post-intervention, 3-month follow-up ] [ Designated as safety issue: No ]
    The PROMIS measure for depression was administered


Enrollment: 42
Study Start Date: January 2010
Study Completion Date: June 2011
Primary Completion Date: June 2011 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: loving-kindness meditation Behavioral: loving-kindness meditation
A 12-week duration, 90 minute per session loving-kindness meditation course

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • posttraumatic stress disorder

Exclusion Criteria:

  • psychosis
  • borderline personality disorder
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01607632

Locations
United States, Washington
VA Puget Sound
Seattle, Washington, United States, 98108
Sponsors and Collaborators
Seattle Institute for Biomedical and Clinical Research
Investigators
Principal Investigator: David Kearney, MD VA Puget Sound
  More Information

No publications provided

Responsible Party: David Kearney, Staff Physician, Seattle Institute for Biomedical and Clinical Research
ClinicalTrials.gov Identifier: NCT01607632     History of Changes
Other Study ID Numbers: 00173
Study First Received: May 23, 2012
Last Updated: May 24, 2012
Health Authority: United States: Institutional Review Board

Keywords provided by Seattle Institute for Biomedical and Clinical Research:
posttraumatic stress
depression

Additional relevant MeSH terms:
Stress Disorders, Post-Traumatic
Stress Disorders, Traumatic
Anxiety Disorders
Mental Disorders

ClinicalTrials.gov processed this record on May 23, 2013